230 related articles for article (PubMed ID: 30267367)
1. Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015.
Roth A; Tran N; Piecara B; Welles S; Shinefeld J; Brady K
AIDS Behav; 2019 Jul; 23(7):1833-1840. PubMed ID: 30267367
[TBL] [Abstract][Full Text] [Related]
2. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
[TBL] [Abstract][Full Text] [Related]
3. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
[TBL] [Abstract][Full Text] [Related]
4. Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
Walters SM; Rivera AV; Starbuck L; Reilly KH; Boldon N; Anderson BJ; Braunstein S
J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3():S383-S391. PubMed ID: 28604443
[TBL] [Abstract][Full Text] [Related]
5. Long-acting Injectable PrEP Interest and General PrEP Awareness among People who Inject Drugs in the San Diego-Tijuana Border Metroplex.
Eger WH; Bazzi AR; Valasek CJ; Vera CF; Harvey-Vera A; Artamonova I; Rangel MG; Strathdee SA; Pines HA
AIDS Behav; 2024 May; 28(5):1650-1661. PubMed ID: 38319461
[TBL] [Abstract][Full Text] [Related]
6. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
Vincent W; McFarland W
Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
[TBL] [Abstract][Full Text] [Related]
7. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
[TBL] [Abstract][Full Text] [Related]
8. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
[TBL] [Abstract][Full Text] [Related]
9. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.
Sherman SG; Schneider KE; Park JN; Allen ST; Hunt D; Chaulk CP; Weir BW
Drug Alcohol Depend; 2019 Feb; 195():148-155. PubMed ID: 30639794
[TBL] [Abstract][Full Text] [Related]
10. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
[TBL] [Abstract][Full Text] [Related]
11. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.
Walters SM; Reilly KH; Neaigus A; Braunstein S
Harm Reduct J; 2017 Jun; 14(1):40. PubMed ID: 28662716
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.
Schneider KE; White RH; Musci RJ; O'Rourke A; Kilkenny ME; Sherman SG; Allen ST
J Stud Alcohol Drugs; 2020 Nov; 81(6):740-749. PubMed ID: 33308403
[TBL] [Abstract][Full Text] [Related]
13. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
[TBL] [Abstract][Full Text] [Related]
14. Awareness and Correlates of HIV Pre-Exposure Prophylaxis (PrEP) Among HIV-negative People Who Access Syringe Services in Seattle, Washington.
Corcorran MA; Scott JD; Tinsley J; Wald A; Glick SN
Subst Use Misuse; 2022; 57(3):337-343. PubMed ID: 34895022
[TBL] [Abstract][Full Text] [Related]
15. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
Jo Y; Bartholomew TS; Doblecki-Lewis S; Rodriguez A; Forrest DW; Tomita-Barber J; Oves J; Tookes HE
PLoS One; 2020; 15(4):e0231424. PubMed ID: 32298320
[TBL] [Abstract][Full Text] [Related]
16. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.
Kuo I; Olsen H; Patrick R; Phillips G; Magnus M; Opoku J; Rawls A; Peterson J; Hamilton F; Kharfen M; Greenberg A
Drug Alcohol Depend; 2016 Jul; 164():8-13. PubMed ID: 27177804
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon.
Spencer HC; Babiarz J; Menza TW
Int J STD AIDS; 2023 Jul; 34(8):567-573. PubMed ID: 36949570
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia.
Read P; Chronister KJ; Kostovski C; Harrod ME; Salmon A; Jauncey M
Sex Health; 2019 Aug; 16(4):383-388. PubMed ID: 31203837
[TBL] [Abstract][Full Text] [Related]
20. Awareness and uptake of oral pre-exposure prophylaxis among adolescent and young key populations in Nigeria: a secondary data analysis of the 2020 Integrated Biological & Behavioural Surveillance Survey.
Olakunde BO; Folala-Anoemuah Y; Ujam C; Ndukwe CD; Olaifa Y; Yahaya HB; Bello H; Ogundipe A
AIDS Care; 2024 Jan; 36(1):146-152. PubMed ID: 37683258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
